India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Thematic (Sector/Industry)

<ul>
<li>The Pahalgam terrorist attack on April 25, 2025 caused a brief market correction, with the Nifty 50 falling by 0.86% which was in line with past trends.</li>
<li>Historically, geopolitical shocks like the Kargil War (1999) and Pulwama attack (2019) caused minimal corrections, with the Sensex rebounding by 33% post-Kargil and 400 points in two sessions after 26/11.</li>
<li>The market’s swift recovery, with the Nifty gaining 1.20% on April 28, 2025. Experts project a mild 5-10% correction if tensions escalate, followed by a return to fundamentals.</li>
</ul>


The Pahalgam terrorist attack on April 25, 2025 caused a brief market correction, with the Nifty 50 falling by 0.86% which was in line with past trends.
Historically, geopolitical shocks like the Kargil War (1999) and Pulwama attack (2019) caused minimal corrections, with the Sensex rebounding by 33% post-Kargil and 400 points in two sessions after 26/11.
The market’s swift recovery, with the Nifty gaining 1.20% on April 28, 2025. Experts project a mild 5-10% correction if tensions escalate, followed by a return to fundamentals.


Chartered Insights: Impact of Pahalgam Terrorist Attack On Markets

Market & Forensics Analyst, Beat the Street

Nimish Maheshwari

Market & Forensics Analyst

<ul>
<li>Steelmakers are set for strong Q4 growth, with rising HRC prices and falling raw material costs boosting operating margins by INR 1,200-1,800 per tonne for steelmakers.</li>
<li>Lower input costs, particularly coking coal along with GOI's ADD will significantly improve profitability for steelmakers.</li>
<li>
<a href="https://www.smartkarma.com/entities/jsw-steel-ltd" target="_blank" data-smartkarma-citation="entities:18561:1" rel="noopener">JSW Steel Ltd (JSTL IN)</a> , <a href="https://www.smartkarma.com/entities/jindal-steel-power-ltd" target="_blank" data-smartkarma-citation="entities:6614:1" rel="noopener">Jindal Steel &amp; Power (JSP IN)</a> , <a href="https://www.smartkarma.com/entities/tata-steel-ltd" target="_blank" data-smartkarma-citation="entities:20934:1" rel="noopener">Tata Steel Ltd (TATA IN), </a> <a href="https://www.smartkarma.com/entities/steel-authority-of-india" target="_blank" data-smartkarma-citation="entities:14323:1" rel="noopener">Steel Authority of India (SAIL IN)  expects surge in PAT upto 700%.</a>
</li>
</ul>


Steelmakers are set for strong Q4 growth, with rising HRC prices and falling raw material costs boosting operating margins by INR 1,200-1,800 per tonne for steelmakers.
Lower input costs, particularly coking coal along with GOI's ADD will significantly improve profitability for steelmakers.

JSW Steel Ltd (JSTL IN) , Jindal Steel &amp; Power (JSP IN) , Tata Steel Ltd (TATA IN),  Steel Authority of India (SAIL IN)  expects surge in PAT upto 700%.



Themes of India: Revival of Indian Steel Industry Cycle In Q4 Feasible?

Global Macro Strategist, Westbourne Research Services

Sharmila Whelan

Global Macro Strategist

Macroeconomic, Geopolitical and Policy Forecasting

Westbourne Research Services

Westbourne Research is a global macroeconomic, geopolitical and policy forecasting and strategic advisory consultancy. Located in London, UK and serving clients globally. Our knowledge is deep, spanning all asset classes and key industrial sectors. Our perspective is global. Our presence is expansive, with 30 years analysing and working in developed and emerging markets. We are uniquely India and China specialists.

Cross Asset Strategy

<ul>
<li>Bond holders should be concerned  about Europe’s fiscal position, which is less rosy than official numbers suggest,  and the looming surge in defence spending.   Stay underweight European government bonds.</li>
<li>Europe’s urgently needs to strengthen its defences. There is some catching up to do -  Europe still spends half as much as the US’s and the gap has widened.</li>
<li>Weaning itself off US arms won’t be easy or quick. Overweight US defence stocks.</li>
</ul>


Bond holders should be concerned  about Europe’s fiscal position, which is less rosy than official numbers suggest,  and the looming surge in defence spending.   Stay underweight European government bonds.
Europe’s urgently needs to strengthen its defences. There is some catching up to do -  Europe still spends half as much as the US’s and the gap has widened.
Weaning itself off US arms won’t be easy or quick. Overweight US defence stocks.


<ul>
<li>Pakistan’s suspension of bilateral trade with India impacts supply chains, but India’s diversified trade routes through third countries like Dubai and Singapore provide resilience.  </li>
<li>India’s trade surplus with Pakistan is at risk, particularly in key sectors like pharmaceuticals, tea, and fertilizers, which could cause supply disruptions in Pakistan.</li>
<li>India’s economy remains largely unaffected due to negligible imports of $0.48 Million, while Pakistan faces heightened inflation and shortages of critical goods, deepening economic strain.</li>
</ul>


Pakistan’s suspension of bilateral trade with India impacts supply chains, but India’s diversified trade routes through third countries like Dubai and Singapore provide resilience.  
India’s trade surplus with Pakistan is at risk, particularly in key sectors like pharmaceuticals, tea, and fertilizers, which could cause supply disruptions in Pakistan.
India’s economy remains largely unaffected due to negligible imports of $0.48 Million, while Pakistan faces heightened inflation and shortages of critical goods, deepening economic strain.


Chartered Insights: The Fallout of Indo-Pak Trade Suspension April,2025

Global Healthcare Analyst

Tina Banerjee

<ul>
<li>EMA’s human medicines committee (CHMP) recommended sixteen medicines for approval at its April 2025 meeting. CHMP also adopted positive opinion for nine biosimilar medicines.</li>
<li>Among the new medicines, Vertex’s triple combination cystic fibrosis drug Alyftrek, Amgen’s Thyroid eye disease drug Tepezza, and Jazz Pharmaceutical’s billiary tract cancer drug Ziihera have potential to become blockbusters.</li>
<li>The Agency has recommended the refusal of the marketing authorization for Eli Lilly’s Alzheimer’s Disease drug Kisunla. Eli Lilly may ask for a re-examination of the opinion within 15 days.</li>
</ul>


EMA’s human medicines committee (CHMP) recommended sixteen medicines for approval at its April 2025 meeting. CHMP also adopted positive opinion for nine biosimilar medicines.
Among the new medicines, Vertex’s triple combination cystic fibrosis drug Alyftrek, Amgen’s Thyroid eye disease drug Tepezza, and Jazz Pharmaceutical’s billiary tract cancer drug Ziihera have potential to become blockbusters.
The Agency has recommended the refusal of the marketing authorization for Eli Lilly’s Alzheimer’s Disease drug Kisunla. Eli Lilly may ask for a re-examination of the opinion within 15 days.


CHMP Meeting Update April 2025: Sixteen New Medicines Recommended For Approval

United Arab Emirates
Insights on United Arab Emirates

Chartered Insights: Impact of Pahalgam Terrorist Attack On Markets

The Pahalgam terrorist attack led to a brief market correction, but history shows that geopolitical shocks have minimal long-term impact on the...

Sudarshan Bhandari

Themes of India: Revival of Indian Steel Industry Cycle In Q4 Feasible?

Steelmakers in India are poised for strong Q4 growth, with rising HRC prices and falling RM costs boosting OPM by INR 1,200-1,800/ tonne, leading...

Nimish Maheshwari

Europe Vs NATO & Trump - U/W Bonds

European defence spending is still topical and has implications for euro-area public finances and reinforces the underweight on bonds.

Sharmila Whelan

Chartered Insights: The Fallout of Indo-Pak Trade Suspension April,2025

Pakistan's suspension of trade with India impacts supply chains, but India's routes through third countries provide resilience, risking India's...

Sudarshan Bhandari

CHMP Meeting Update April 2025: Sixteen New Medicines Recommended For Approval

Among the new medicines, Vertex’s triple combination CF drug Alyftrek, Amgen’s Thyroid eye disease drug Tepezza, and Jazz Pharmaceutical’s cancer...

Tina Banerjee

Chartered Insights: Impact of Pahalgam Terrorist Attack On Markets

​The Pahalgam terrorist attack led to a brief market correction, but history shows that geopolitical shocks have minimal long-term impact on the...

Sudarshan Bhandari

Themes of India: Revival of Indian Steel Industry Cycle In Q4 Feasible?

​Steelmakers in India are poised for strong Q4 growth, with rising HRC prices and falling RM costs boosting OPM by INR 1,200-1,800/ tonne, leading...

Nimish Maheshwari

Europe Vs NATO & Trump - U/W Bonds

European defence spending is still topical and has implications for euro-area public finances and reinforces the underweight on bonds.

Sharmila Whelan

Chartered Insights: The Fallout of Indo-Pak Trade Suspension April,2025

​Pakistan's suspension of trade with India impacts supply chains, but India's routes through third countries provide resilience, risking India's...

Sudarshan Bhandari

CHMP Meeting Update April 2025: Sixteen New Medicines Recommended For Approval

Among the new medicines, Vertex’s triple combination CF drug Alyftrek, Amgen’s Thyroid eye disease drug Tepezza, and Jazz Pharmaceutical’s cancer...

Tina Banerjee

The Pahalgam terrorist attack led to a brief market correction, but history shows that geopolitical shocks have minimal long-term impact on the...

Steelmakers in India are poised for strong Q4 growth, with rising HRC prices and falling RM costs boosting OPM by INR 1,200-1,800/ tonne, leading...

Pakistan's suspension of trade with India impacts supply chains, but India's routes through third countries provide resilience, risking India's...